Hepatitis Forums
Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on August 25, 2017, 10:13:32 am
-
Having even a low level of hepatitis B virus (HBV) while on treatment with Baraclude (entecavir) increases the risk of liver cancer, according to a recent report in Hepatology. These findings suggest that low-level viral load is not harmless, but the best approach for managing it remains unclear.
Over years or decades, chronic HBV infection can lead to serious liver disease, including cirrhosis and hepatocellular carcinoma (HCC), a type of primary liver cancer.
Read more...
https://www.hepmag.com/article/lowlevel-hepatitis-b-viral-load-raises-liver-cancer-risk